Aulos Bioscience Advances AU-007 to Phase 2 Portion of Phase 1/2 Study Evaluating Computationally Designed IL-2 Antibody for Treatment of Solid Tumors
LARKSPUR, Calif.--(BUSINESS WIRE)--Dec 18, 2023--
Source: eagletribune.com
Aulos Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Aulos Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Aulos Bioscience Today - Breaking & Trending Today
New Phase 1 Dose Escalation Data Show Well-Tolerated Safety Profile and Anti-Tumor Activity for Aulos Bioscience's AU-007 at Society for Immunotherapy of Cancer (SITC) Annual Meeting | Region
LARKSPUR, Calif.--(BUSINESS WIRE)--Nov 3, 2023--
Source: eagletribune.com
Aulos Bioscience Raises $20M in Series A Extension Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Made in Israel: First AI-designed Antibody Could Lead to Eradication of Tumors - Tech News
A Computer May Design the Perfect Antibody to Fight Cancer in a Breakthrough for Medicine. Prof. Yanay Ofran Explains Why Testing It on Mice Can Be Misleading, and What Limits Creativity in Biotech Companies: 'They're Searching for a New Biology and Trying to Treat It Using Old Technology. We Do the Opposite'
Source: haaretz.com
Monoclonal Antibodies Clinical Trial Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain
/PRNewswire/ -- DelveInsight's 'Monoclonal Antibodies Competitive Landscape – 2023' report provides comprehensive global coverage of available, marketed, and...
Source: prnewswire.com